Risedronate prevents bone loss in breast cancer survivors: A two-year, randomized, double-blind, placebo-controlled clinical trial

被引：0
|
作者：
Greenspan, S. L. [1 ]
Vujevich, K. T. [1 ]
Bhattachary, R. [2 ]
Perera, S. [1 ]
Brufsky, A. [1 ]
Lembersky, B. C. [1 ]
Vogel, V. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Univ Kansas, Kansas City, KS USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1017
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [41] Alendronate prevents bone loss in patients with acute spinal cord injury: A randomized, double-blind, placebo-controlled study
    Gilchrist, N. L.
    Frampton, C. M.
    Acland, R. H.
    Nicholls, M. G.
    March, R. L.
    Maguire, P.
    Heard, A.
    Reilly, P.
    Marshall, K.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (04): : 1385 - 1390
  • [42] A Randomized, Double-blind, Placebo-controlled Trial of Alendronate Treatment for Fibrous Dysplasia of Bone
    Boyce, Alison
    Kelly, Marilyn
    Brillante, Beth
    Kushner, Harvey
    Wientroub, Shlomo
    Riminucci, Mara
    Bianco, Paolo
    Robey, Pamela
    Collins, Michael
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [43] Ibandronate Prevents Bone Loss and Reduces Vertebral Fracture Risk in Male Cardiac Transplant Patients: A Randomized Double-Blind, Placebo-Controlled Trial
    Fahrleitner-Pammer, Astrid
    Piswanger-Soelkner, Jutta Claudia
    Pieber, Thomas Rudolf
    Obermayer-Pietsch, Barbara Maria
    Pilz, Stefan
    Dimai, Hans Peter
    Prenner, Guenther
    Tscheliessnigg, Karl-Heinz
    Hauge, Ellen
    Portugaller, Rupert Horst
    Dobnig, Harald
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (07) : 1335 - 1344
  • [44] Lactobacillus reuteri reduces bone loss in older women with low bone mineral density: a randomized, placebo-controlled, double-blind, clinical trial
    Nilsson, A. G.
    Sundh, D.
    Backhed, F.
    Lorentzon, M.
    JOURNAL OF INTERNAL MEDICINE, 2018, 284 (03) : 307 - 317
  • [45] Risedronate therapy prevents corticosteroid-induced bone loss - A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
    Cohen, S
    Levy, RM
    Keller, M
    Boling, E
    Emkey, RD
    Greenwald, M
    Zizic, TM
    Wallach, S
    Sewell, KL
    Lukert, BP
    Axelrod, DW
    Chines, AA
    ARTHRITIS AND RHEUMATISM, 1999, 42 (11): : 2309 - 2318
  • [46] A Two-Year, Double-Blind, Randomized Placebo-Controlled Trial of Oral Green Tea Polyphenols on the Long-Term Clinical and Histologic Appearance of Photoaging Skin
    Janjua, Roohina
    Munoz, Claudia
    Gorell, Emily
    Rehmus, Wingfield
    Egbert, Barbara
    Kern, Dale
    Chang, Anne Lynn S.
    DERMATOLOGIC SURGERY, 2009, 35 (07) : 1057 - 1065
  • [47] The clinical effect of benesco™ on reflux symptoms: A double-blind randomized placebo-controlled trial
    Kuipers, Thijs
    Oude Nijhuis, Renske A. B.
    Schuitenmaker, Jeroen M.
    Bredenoord, Albert J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35 (10):
  • [48] Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial
    Campillo, Jeremy T.
    Bikita, Paul
    Hemilembolo, Marlhand
    Louya, Frederic
    Missamou, Francois
    Pion, Sebastien D. S.
    Boussinesq, Michel
    Chesnais, CedricB
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : 19 - 27
  • [49] A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis
    Nassiri-Kashani, M
    Firooz, A
    Khamesipour, A
    Moitahed, F
    Nilforoushzadeh, M
    Hejazi, H
    Bouzari, N
    Dowlati, Y
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2005, 19 (01) : 80 - 83
  • [50] HSDD, Flibanserin, and Eye Dynamics: A Double-Blind Randomized Placebo-Controlled Clinical Trial
    Cacioppo, Stephanie
    Kaske, Erika
    Siewsrichol, Wasuwat
    Millheiser, Leah
    OBSTETRICS AND GYNECOLOGY, 2019, 133 : 101S - 101S
12345